Literature DB >> 23224798

Postprocedural neuropathy after atrial fibrillation ablation.

Yeruva Madhu Reddy1, Dhssraj Singh, Vineela Chikkam, Sudharani Bommana, Donita Atkins, Atul Verma, Vijay Swarup, Yariv Khaykin, Srinivas Nalamachu, Mamatha Pasnoor, Dhanunjaya Lakkireddy.   

Abstract

PURPOSE: Access-related neuropathy after atrial fibrillation (AF) ablation is underappreciated. We intend to describe the incidence, management, and prognosis of postprocedural neuropathy after AF ablation.
METHODS: We performed a retrospective analysis of all consecutive patients with postprocedural neuropathy who underwent AF ablation in three high-volume tertiary care hospitals between January 2007 and April 2011.
RESULTS: Of the 3,128 patients who underwent AF ablation during the study period, 25 (0.8 %) patients had postprocedural neuropathy and were included in the current study. Mean age was 58.5 ± 11.5 years with 18 (72 %) being males and 14 (56 %) having paroxysmal AF. Ulnar nerve, lateral femoral cutaneous nerve manifesting as meralgia paresthetica, and femoral nerve were involved in 5 (20 %), 13 (54 %), and 7 (26 %) of the patients, respectively. Majority of neuropathies were associated with periprocedural hematomas (19, 76 %), and a quarter (19/72, 26 %) of all hematomas were associated with neuropathy. Initial treatment included warm and cold compresses followed by nonsteroidal anti-inflammatory and narcotic pain medications. In addition to the above regimen, in some patients (11, 44 %), oral gabapentin was used and it was associated with a shorter time to symptom resolution (9.4 vs. 14.1 days, p = 0.007). All patients were symptom free within 90 days of the procedure.
CONCLUSION: Postprocedural neuropathy after AF ablation is rare and is frequently associated with a periprocedural hematoma. Patients typically become symptom free within 90 days of the procedure, and gabapentin may have a role in earlier symptom resolution.

Entities:  

Mesh:

Year:  2012        PMID: 23224798     DOI: 10.1007/s10840-012-9724-z

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  23 in total

1.  Femoral nerve palsy: an unusual complication after femoral vein puncture in a patient with severe coagulopathy.

Authors:  K M Ho; H H Lim
Journal:  Anesth Analg       Date:  1999-09       Impact factor: 5.108

Review 2.  Meralgia paresthetica: what an anesthesiologist needs to know.

Authors:  Grace K M Hui; Philip W H Peng
Journal:  Reg Anesth Pain Med       Date:  2011 Mar-Apr       Impact factor: 6.288

3.  Femoral neuropathy following cardiac catheterization for balloon mitral valvotomy.

Authors:  A Kuruvilla; G Kuruttukulam; B Francis
Journal:  Int J Cardiol       Date:  1999-10-31       Impact factor: 4.164

4.  Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study).

Authors:  Giuseppe Stabile; Emanuele Bertaglia; Gaetano Senatore; Antonio De Simone; Franco Zoppo; Giovanni Donnici; Pietro Turco; Pietro Pascotto; Massimo Fazzari; Dino Franco Vitale
Journal:  Eur Heart J       Date:  2005-10-07       Impact factor: 29.983

5.  Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

Authors:  Riccardo Cappato; Hugh Calkins; Shih-Ann Chen; Wyn Davies; Yoshito Iesaka; Jonathan Kalman; You-Ho Kim; George Klein; Andrea Natale; Douglas Packer; Allan Skanes; Federico Ambrogi; Elia Biganzoli
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-12-07

6.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.

Authors:  Oussama M Wazni; Nassir F Marrouche; David O Martin; Atul Verma; Mandeep Bhargava; Walid Saliba; Dianna Bash; Robert Schweikert; Johannes Brachmann; Jens Gunther; Klaus Gutleben; Ennio Pisano; Dominico Potenza; Raffaele Fanelli; Antonio Raviele; Sakis Themistoclakis; Antonio Rossillo; Aldo Bonso; Andrea Natale
Journal:  JAMA       Date:  2005-06-01       Impact factor: 56.272

7.  Meralgia paresthetica: an unusual complication of cardiac catheterization via the femoral artery.

Authors:  Rob Butler; Mark W I Webster
Journal:  Catheter Cardiovasc Interv       Date:  2002-05       Impact factor: 2.692

8.  Diagnostic and prognostic value of electrophysiologic tests in meralgia paresthetica.

Authors:  A Lagueny; M M Deliac; P Deliac; A Durandeau
Journal:  Muscle Nerve       Date:  1991-01       Impact factor: 3.217

9.  Isolated femoral nerve neuropathy after intra-aortic balloon pump treatment.

Authors:  Ho-Tsung Hsin; Juey-Jen Hwang
Journal:  J Formos Med Assoc       Date:  2007-03       Impact factor: 3.282

10.  Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications.

Authors:  Nassir F Marrouche; David O Martin; Oussama Wazni; A Marc Gillinov; Allan Klein; Mandeep Bhargava; Eduardo Saad; Dianna Bash; Hirotsugu Yamada; Wael Jaber; Robert Schweikert; Patrick Tchou; Ahmad Abdul-Karim; Walid Saliba; Andrea Natale
Journal:  Circulation       Date:  2003-05-19       Impact factor: 29.690

View more
  3 in total

1.  Beneath the Surface: Massive Retroperitoneal Liposarcoma Masquerading as Meralgia Paresthetica.

Authors:  John W Ostrominski; Qin Huang; Yelena Kamenker-Orlov
Journal:  Fed Pract       Date:  2021-05

Review 2.  Meralgia Paresthetica.

Authors:  Jane Nithya Tolson Solomons; Afrin Sagir; Cyrus Yazdi
Journal:  Curr Pain Headache Rep       Date:  2022-05-27

3.  Figure-of-eight suture for venous hemostasis in fully anticoagulated patients after atrial fibrillation catheter ablation.

Authors:  Umashankar Lakshmanadoss; Wai Shun Wong; Ilana Kutinsky; M Rizwan Khalid; Brian Williamson; David E Haines
Journal:  Indian Pacing Electrophysiol J       Date:  2017-02-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.